Jump to content

Dear members, finally, we decided to refresh our theme. Decision was brought based on multiple factors, primarily because of technical needs as old one is not compatible with a new platform version, but also because you all asked for a darker theme.
Here you go!

Please head here if you want to vote https://www.elite7hackers.net/topic/411861-the-new-theme/

 

This site uses cookies! Learn More

This site uses cookies!

For providing our services, we do use cookies.
But get used, this is what most of modern web do!
However we have to warn you since we are obligated to so due to EU laws.

By continuing to use this site, you agree to allow us to store cookies on your computer. :)
And no, we will not eat your computer nor you will be able to eat those cookies :P

Sign in to follow this  
Rahuls99

Biosimilars Regulatory, Clinical, and Biopharmaceutical Development

Recommended Posts


1901140444040098.jpg
Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development (AAPS Advances in the Pharmaceutical Sciences Series, Book 34) by Hiten J. Gutka and Harry Yang
English | 2018 | ISBN: 3319996797 | 709 pages | PDF | 11,7 MB



This book provides a comprehensive overview of the biosimilar regulatory framework, the development process and clinical aspects for development of biosimilars. The development path of a biosimilar is just as unique as a development path of a new drug, tailored by the mechanism of action, the quality of the molecule, published information on the reference product, the current competitive environment, the target market and regulatory guidance, and most importantly, the emerging totality of evidence for the proposed biosimilar during development.
For the ease of readers, the book comprises of six sections as follows:
Section I: Business, Health Economics and Intellectual Property Landscape for Biosimilars
Section II: Regulatory Aspects of Development and Approval for Biosimilars
Section III: Biopharmaceutical Development and Manufacturing of Biosimilars
Section IV: Analytical Similarity Considerations for Biosimilars
Section V: Clinical aspects of Biosimilar Development
Section VI: Biosimilars- Global Development and Clinical Experience
Chapters have been written by one or more experts from academia, industry or regulatory agencies who have been involved with one or more aspects of biosimilar product development. The authors and editors have an expertise in commercialization and pricing of biosimilars, intellectual property considerations for biosimilars, chemistry manufacturing controls (CMC) and analytical development for biosimilars, regulatory and clinical aspects of biosimilar development. Besides the industry practitioners, the book includes several contributions from regulators across the globe.


Buy Premium From My Links To Get Resumable Support,Max Speed & Support Me
[b]Download (Uploadgig)[/b]
https://uploadgig.com/file/download/815a511aDf6F123f/dmpvg.Biosimilars.Regulatory.Clinical.and.Biopharmaceutical.Development.rar
Download ( Rapidgator )
https://rapidgator.net/file/e6cea98a357e31ea355a78c10882e0c5/dmpvg.Biosimilars.Regulatory.Clinical.and.Biopharmaceutical.Development.rar
Download ( NitroFlare )
http://nitroflare.com/view/D57CD46B0280C03/dmpvg.Biosimilars.Regulatory.Clinical.and.Biopharmaceutical.Development.rar

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

Elite7Hackers Netwok

Hack the imagination!

Support and inquiries

Open support ticket here or email us at [email protected]

Highlights

Highlighted/recommended lights

×

Important Information

By using this site, you agree to our Privacy Policy and Terms of Use.